Herantis Pharma to participate in upcoming November investor conferences
Herantis Pharma Plc, Press Release, 7 November 2022 at 09:00 A.M. EEST Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that the company will participate in the following upcoming investor conferences: Helsinki Sijoittajamessut (The Investor Fair 2022) Date: November 16, 2022 Location: Messukeskus Expo Centre, Helsinki, Finland Carlsquare Life Science Investor Day Date: November 17, 2022 Location: Stockholm, Sweden Redeye Life Science Day Date: November 24, 2022 Location: